Pharmacogenomics in cardiac therapy: Personalizing treatment for heart health

Abstract excerpt

Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide. Genetics factors play a significant role in the development of CVDs, which may result from monogenic or polygenic influences. These genetic contributions can lead to various life-threatening conditions such as cardiomyopathies, aortopathies, dyslipidemias, and arrhythmias, many of which are associated with sudden cardiac...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hormonal Regulation and Hypertension
• Share to Pharmacogenetics and Drug Metabolism
• Share to Receptor Mechanisms and Signaling